Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: The French multicentre study

European Respiratory Journal

Volumn 33, Issue 5, 2009, Pages 1062-1067

  Pepin J L ^a,b   Viot Blanc, V ^c,d   Escourrou, P ^e   Racineux, J L ^f   Sapene, M ^g   Levy, P ^a,b   Dervaux, B ^h   Lenne, X ^h   Mallart, A ⁱ  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d Cephalon   (France)

^e HÔPITAL ANTOINE BÉCLÈRE   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g Unité Sommeil et Vigilance Polyclinique Bordeaux Cauderan   (France)

^h CRESGE   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Continuous positive airway pressure; Modafinil; Prevalence; Residual excessive sleepiness; Sleep apnoea

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION INVENTORY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESIDUAL EXCESSIVE SLEEPINESS; RESTLESS LEGS SYNDROME; SLEEP APNEA SYNDROME; SOMNOLENCE; SYMPTOMATOLOGY;

ANTHROPOMETRY; CHI-SQUARE DISTRIBUTION; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-SECTIONAL STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; PREVALENCE; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA SYNDROMES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 66749142976     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00016808     Document Type: Article

References (32)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-1239.
2. Engleman HM, Douglas NJ. Sleep. 4: sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/ hypopnoea syndrome. Thorax 2004; 59: 618-622.
3. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 2003; 163:565-571.
4. Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; 3: CD001106.
5. Marshall NS, Barnes M, Travier N, et al. Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis. Thorax 2006; 61: 430-434.
6. Lloberes P, Marti S, Sampol G, et al. Predictive factors of quality-of-life improvement and continuous positive airway pressure use in patients with sleep apnea-hypop-nea syndrome: study at 1 year. Chest 2004; 126: 1241-1247.
7. Black J. Sleepiness and residual sleepiness in adults with obstructive sleep apnea. Respir Physiol Neurobiol 2003; 136: 211-220.
8. Schwartz JR, Hirshkowitz M, Erman MK, Schmidt- Nowara W. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest 2003; 124: 2192-2199.
9. Dinges DF, Weaver TE. Effects of modafinil on sustained attention performance and quality of life in OSA patients with residual sleepiness while being treated with nCPAP. Sleep Med 2003; 4: 393-402.
10. Kingshott RN, Vennelle M, Coleman EL, Engleman HM, Mackay TW, Douglas NJ. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 2001; 163: 918-923.
11. Pack AI, Black JE, Schwartz JR, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 2001; 164: 1675-1681.
12. Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypop-nea syndrome. Sleep 2005; 28: 464-471.
13. Roth T, White D, Schmidt-Nowara W, et al. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults. Clin Ther 2006; 28: 689-706.
14. Hirshkowitz M, Black JE, Wesnes K, Niebler G, Arora S, Roth T. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med 2007; 101: 616-627.
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
16. Fornas C, Ballester E, Arteta E, et al. Measurement of general health status in obstructive sleep apnea hypopnea patients. Sleep 1995; 18: 876-879.
17. Meslier N, Lebrun T, Grillier-Lanoir V, et al. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-192.
18. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini- International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: Suppl. 20, 22-33.
19. Santamaria J, Iranzo A, Ma Montserrat J, de Pablo J. Persistent sleepiness in CPAP treated obstructive sleep apnea patients: evaluation and treatment. Sleep Med Rev 2007; 11: 195-207.
20. Veasey SC, Guilleminault C, Strohl KP, Sanders MH, Ballard RD, Magalang UJ. Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 2006; 29: 1036-1044.
21. Nguyen XL, Rakotonanahary D, Chaskalovic J, et al. Residual subjective daytime sleepiness under CPAP treatment in initially somnolent apnea patients: apilot study using data mining methods. Sleep Med 2008; 9: 511-516.
22. Guilleminault C, Philip P. Tiredness and somnolence despite initial treatment of obstructive sleep apnea syndrome (what to do when an OSAS patient stays hypersomnolent despite treatment). Sleep 1996; 19: Suppl. 9, S117-S122.
23. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005; 90: 4510-4515.
24. Baldwin DS, Papakostas GI. Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry 2006; 67: Suppl. 6, 9-15.
25. Tison F, Crochard A, Leger D, Bouee S, Lainey E, El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology 2005; 65: 239-246.
26. Holmes R, Tluk S, Metta V, et al. Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. J Neural Transm 2007; 114: 929-934.
27. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006; 7: 545-552.
28. Morrell MJ. Residual sleepiness in patients with optimally treated sleep apnea: a case for hypoxia-induced oxidative brain injury. Sleep 2004; 27: 186-187.
29. Alchanatis M, Deligiorgis N, Zias N, et al. Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy study. Eur Respir J 2004; 24: 980-986.
30. Tonon C, Vetrugno R, Lodi R, et al. Proton magnetic resonance spectroscopy study of brain metabolism in obstructive sleep apnoea syndrome before and after continuous positive airway pressure treatment. Sleep 2007; 30: 305-311.
31. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea- hypopnea syndrome. Am J Respir Crit Care Med 2001; 164:939-943.
32. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000; 16: 118-122.